Retrieved from CDC website
If it does, Eli Lilly will have a compound that makes their already-successful tirzepatide look like a stepping stone
However, the recent FDA approvals of Wegovy (2021) and Zebound (2023) for weight loss have been met with a tremendous increase in demand for these drugs
Understanding these patterns helps research teams implement targeted assessment protocols and early intervention strategies
Discover the typical timeline for observing noticeable changes and factors that can influence the speed of your progress
I only really hear about microdosing when it comes to compounding medications, which we never recommend, or off-label use of GLP-1s for longevity, addiction, and other indications. Although many doctors are writing prescriptions for GLP-1 microdosing, experts are concerned that they may not always be acting scrupulously, especially when working with less-reputable online compounding pharmacies